Lower costs with sequential high-dose chemotherapy in breast cancer

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.422, 2003-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Chemotherapy in Breast Cancer

By Lake Diana E. Hudis Clifford A.

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1851-1860

Adis International

Access to resources Recommend Favorite

High-dose chemotherapy regimen well tolerated in breast cancer

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?: An Economic Assessment in Inflammatory Breast Cancer

By Marino P.

PharmacoEconomics, Vol. 21, Iss. 11, 2003-01 ,pp. : 807-818

Adis International

Access to resources Recommend Favorite

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer: Where Are We Now?

By Gerrero R.M. Stein S. Stadtmauer E.A.

Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. : 475-485

Adis International

Access to resources Recommend Favorite

Pharmacodynamics of High-Dose Chemotherapy

Current Drug Metabolism, Vol. 2, Iss. 1, 2001-03 ,pp. : 53-66

Bentham Science Publishers

Access to resources Recommend Favorite